S
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
Recent Filings
- 44.7 KBSucampo Pharmaceuticals, Inc.Jun 6, 6:02 PM ET·0001171843-16-010524
- 44.6 KBSucampo Pharmaceuticals, Inc.Jun 6, 6:02 PM ET·0001171843-16-010523
- 44.5 KBSucampo Pharmaceuticals, Inc.Jun 6, 6:01 PM ET·0001171843-16-010522
- 44.6 KBSucampo Pharmaceuticals, Inc.Jun 6, 6:01 PM ET·0001171843-16-010521
- 44.6 KBSucampo Pharmaceuticals, Inc.Jun 6, 6:01 PM ET·0001171843-16-010520
- 411.3 KBSucampo Pharmaceuticals, Inc.Jan 9, 5:05 PM ET·0001171843-14-000111
- 44.9 KBSucampo Pharmaceuticals, Inc.Jan 6, 2:39 PM ET·0001171843-14-000051
- 8-K1.6 MBSucampo Pharmaceuticals, Inc.Jul 16, 6:45 AM ET·0001157523-13-003332
- 8-K9.1 MBSucampo Pharmaceuticals, Inc.Sep 28, 6:46 AM ET·0001157523-12-004982
- 8-K15.9 KBSucampo Pharmaceuticals, Inc.Jun 29, 4:30 PM ET·0001157523-12-003508
Insiders
10- Claiborne Cary JChief Financial Officer
- Dolecek Gayle RSVP Research & Development
- Egan JamesChief Operating Officer
- FERRARA ANDREW JDirector
- JOHNSON JOHNDirector
- KAISER RONALD WCFO
- Knapp Thomas JSVP, Gen Counsel & Corp. Secy
- Miele Stanley GSVP, Sales and Marketing
- OCONNELL MAUREENDirector
- Smilek JanChief Accounting Officer
Tickers
No tickers on record
Addresses
business
805 KING FARM BOULEVARD, SUITE 550
ROCKVILLE, MD, 20850
mailing
805 KING FARM BOULEVARD, SUITE 550
ROCKVILLE, MD, 20850